Novadopa 250
Summary
Date Recall was issued:
Product Name:
Manufacturer:
Recalling Firm:
Batch(es):
Manufacturing Date:
Expiry Date:
Reason for Recall:
28th February 2020
Novadopa 250mg
Pharmanova Limited
H009
October 2018
September 2021
Substandard (Product failed quality evaluation with respect to Assay, Uniformity of dosage units and appearance of tablets)
Announcement
This recall is necessitated as a result of warehouse market surveillance conducted at the warehouse. Actual product specification is a powder for oral suspension. The affected batches were caked and not free flowing. This makes the product substandard and therefore not recommended for its intended use.
